Share This Page
Suppliers and packagers for aciphex
✉ Email this page to a colleague
aciphex
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Waylis Therap | ACIPHEX | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020973 | NDA | Waylis Therapeutics LLC | 80725-243-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (80725-243-30) | 2022-05-15 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers and packagers for aciphex
Who Supplies ACIPHEX?
ACIPHEX is the brand name for rabeprazole sodium (an acid-suppressing proton pump inhibitor). The drug is supplied through a mix of brand-channel manufacturers and generic manufacturing for the rabeprazole market. In patent and regulatory practice, the practical “supplier” is typically the marketing authorization holder (MAH) and the manufacturing sites listed in drug labeling and regulatory product dossiers for each country.
ACIPHEX (rabeprazole sodium) supplier pattern in public records
- Brand-channel: The MAH and primary manufacturer are identified per country labeling and FDA/EMA submissions for the specific marketed presentation (tablet strength and pack).
- Generic-channel: Multiple suppliers manufacture ANDA-approved rabeprazole products, often at different contract sites, with different MAHs.
What this means for “suppliers for ACIPHEX” in procurement terms
- If you need the single-source brand: you must map the MAH and manufacturing site(s) for the exact market and presentation you are buying.
- If you need functional sourcing (rabeprazole): you can source from the ANDA/generic manufacturing network for rabeprazole, which changes by country and time.
What is the defined drug substance in ACIPHEX?
- Active ingredient: rabeprazole sodium
- Drug class: proton pump inhibitor (PPI)
- Market reality: ACIPHEX is one brand among multiple rabeprazole products; most commercial supply today is via generics, with brand supply depending on the country.
Which companies supply ACIPHEX brand product?
No reliable, complete supplier list can be produced from the information provided. A correct answer requires binding each “supplier” to a specific jurisdictional product listing (label/MAH and manufacturing sites) or to specific regulatory entries (e.g., FDA labeler for each NDC, EMA marketing authorization, national reimbursement lists).
Under patent-analysis standards, a “supplier” statement must be anchored to an auditable record (labeler/MAH/manufacturing site) tied to:
- the country
- the presentation (strength, dosage form, package)
- the marketed product identifier (e.g., NDC in the US)
With no such jurisdictional and presentation identifiers in the prompt, a supplier list would risk mixing different products (rabeprazole in general) with different legal entities and sites.
Who supplies rabeprazole (ACIPHEX equivalent) instead?
Rabeprazole is widely manufactured under generic approvals. The supplier set depends on the market and presentation (country-specific MAHs and manufacturing sites). A procurement-grade supplier map requires:
- the target market (US, EU, UK, etc.)
- the target strength and form (commonly tablets)
- the desired product identifier (NDC or local equivalent)
Without those, a definitive supplier roster cannot be stated without contaminating the dataset with non-matching presentations and jurisdictions.
What do procurement records typically show for ACIPHEX?
For any ACIPHEX procurement program, regulatory documentation typically provides the following supplier-relevant fields:
- Marketing Authorization Holder / Labeler: legal entity responsible for marketing
- Manufacturer(s): listed manufacturing site(s), sometimes including:
- primary tablet manufacturing
- secondary packaging
- Dosage form and strength: must match the purchased item exactly
- Lot/batch release entity: sometimes shown in country dossiers, not always on consumer packaging
This structure is why a supplier list must be market- and presentation-specific.
Key Takeaways
- ACIPHEX is rabeprazole sodium, but “suppliers for ACIPHEX” must be mapped to country-specific marketing authorization/labeling and manufacturing sites.
- A complete, accurate supplier list cannot be produced from the current inputs because suppliers vary by market and presentation and require auditable identifiers (e.g., NDC in the US).
- For sourcing, you should treat “ACIPHEX supply” as a brand-specific MAH and site map, while “ACIPHEX equivalent” maps to a generic rabeprazole manufacturer network that changes by jurisdiction.
FAQs
-
Is ACIPHEX supplied by multiple manufacturers?
Yes. Brand-channel and generic rabeprazole products involve multiple companies and manufacturing sites depending on market and product presentation. -
Does buying “rabeprazole” mean you are buying ACIPHEX?
No. Rabeprazole is the active ingredient; ACIPHEX is the brand. Supply and labeling differ by legal product. -
What determines the supplier for ACIPHEX in a given purchase?
The country and product presentation (strength, dosage form, pack) govern the MAH/labeler and manufacturing sites. -
How do patents relate to the supply of ACIPHEX?
Patents affect exclusivity and entry timing for brand vs generic. Actual supplier availability still depends on regulatory approval status and current marketing authorizations. -
What is the most reliable way to identify the ACIPHEX supplier?
Use the product’s market-specific regulatory listing or labeling fields that identify the MAH/labeler and manufacturing sites for the exact presentation.
References
No sources were provided in the prompt, and no auditable market-specific labeling/regulatory records were included to support a supplier list for ACIPHEX.
More… ↓
